FORWARD FEATURES CALENDAR

Latest

Intel

Despite growing fears that higher interest rates will curb the private equity returns, CalPERS, the biggest US public pension plan, is considering upping its allocation to the asset class according to a report by The Financial Times.

Intel

Private-equity firms Francisco Partners and TPG are planning to make a joint take-private bid to acquire US business software solutions provider New Relic in a deal that could be worth over $5 billion, according to a report by Reuters.

Intel

Canadian private equity group Brookfield has put UK and Ireland holiday resort company Center Parcs up for sale with a price tag of between £4 billion and £5 billion, according to a report by The Financial Times.

Intel

TPG Inc, a global alternative asset management firm, is to acquire Angelo Gordon, a $73 billion alternative investment firm focused on credit and real estate investing, in a cash and equity transaction valued at approximately $2.7 billion, based on TPG Inc’s share price as of 12 May, 2023.

Intel

Up to £1.3 billion has been deployed into circular economy investments in a 12 month period, according to a new report from accountancy and business advisory firm BDO LLP, with disclosed capital deployed increasing by 10% from £788 million in 2021 to £879 million in 2022.

Intel

Pantheon, a specialist global private markets investor, has held the final close of its latest private credit secondary offering, Pantheon Credit Opportunities Fund II program, having secured $590 million in commitments from investors, exceeding the initial target size.

Intel

A consortium of private investment firms led by Elliott Investment Management, Patient Square Capital, and Veritas Capital, is to acquire Syneos Health for $43.00 per share in cash in a transaction valued at approximately $7.1 billion, including outstanding debt.

Intel

Apollo Global Management has lowered the target for its new flagship buyout fund, with the firm now expecting to secure capital commitments in the “low $20 billion range” rather than the original figure of $25 billion, according to a report by Bloomberg.

Intel

Warburg Pincus and Advent International are leading a private equity consortium which is in advanced discussions over the acquisition of medical device maker Baxter International Inc’s biopharma solutions business, in a deal that could be worth more than €4 billion, according to a report by the Financial Post.

Partner Content

Climate concerns have remained high on investors’ agendas. But with regulatory, governance and currency concerns still running high, Georges Beukering, Co-founder and Head of Capital Raising, Climate Fund Managers, details the way managers can allay investor apprehension when looking to invest in the space.

Events

12 November, 2026 – 8:00 am

Directory Listings